Sagility Limited share price

Key numbers

Market cap

₹ 20,921 Cr

Current price

₹ 44.69

52-week high / low

₹ 58 / 36

Stock P/E

21.1

Book value

₹ 21.0

Dividend yield

0.45%

ROCE

13.0%

ROE

10.3%

Debt to equity

0.11

Sales growth (3 yrs)

19.5%

Profit growth (3 yrs)

86.1%

1-year return

3.2%

About Sagility Limited

Sagility Limited engages in the rendering voice and non-voice business process management and back-office transaction processing services in India, Jamaica, the Philippines, the United States, and Colombia. The company offers claims and membership managed services, such as digital mailroom, product and plan configuration, enrollment and billing, adjudication and adjustment, and appeals management solutions; engagement services; and payer clincal services. It also provides network operations suite comprising provider credentialing, provider data management, provider accuracy, and provider forward solutions; healthcare consulting services; sagility synchrony; healthcare payment integrity services; and provider services that includes patient access, clinical denials management, revenue cycle management, patient engagement, and coding solutions. In addition, the company offers member lifecycle management, provider lifecycle management, claims management, clinical utilization and care management, payment integrity, and provider revenue cycle management solutions. The company was formerly known as Sagility India Limited and changed its name to Sagility Limited in August 2025. Sagility…

Quarterly results

Consolidated figures in ₹ crores

Concall summary (2026-07-28)

AI summary of the earnings call transcript · tone: Positive · source document

Guidance & outlook

• Our employee strength was 47,307 at the end of Q1, while quarterly voluntary attrition improved significantly to 28.6% from 38.1% in Q4 FY 2026, but was marginally higher than Q1 of FY 2026.
• Our revenue has grown from INR 47,536 million in FY 2024 to INR 76,174 million on a trailing 12 -month June 2026 basis, while adjusted EBITDA increased from INR 11,436 million in FY 2024 to INR 19,228 million on a trailing 12 -months June 2026 basis.

Growth & demand

• Revenue for the quarter was INR 19,635 million, or $207.8 million, representing 27.6% year -on-year growth and 15.2% growth in constant currency.
• Organic growth, excluding CareSeed acquisition, was strong at 27.3% in INR terms and 14.9% in constant currency.

Margins & costs

• On the profitability front, Q1 adjusted EBITDA was INR 4,716 million, or $49.9 million, growing 27.9% year -on-year with a margin of 24%.
• So you see the numbers, $5.1 million was CY 2025 revenue with a 95% recurring revenue and a 31.4% EBITDA margin.

Capex & expansion

• Our CareSeed acquisition helps us on both these fronts, strengthening our capabilities in the quality area, es pecially for Medicare Advantage plans, and giving us 26 additional clients in the mid - and small -segment.
• Cash con version at 70% improved versus FY 2026, supported by healthy operating cash flows and an improved DSO performance, partially offset by earnout payments relating to a previous acquisition.

Balance sheet & cash

• Our balance sheet continues to strengthen, with net debt reducing to INR 1,110 million and net debt-to-adjusted EBITDA at 0.06x.
• We generated INR 3,161 million of operating cash flow during the quarter, and our free cash flow was INR 2,416 million after fixed asset additions of INR 745 million.

Peers in Health Information Services

• Inventurus Knowledge Solutions Limited
• Indegene Limited
• Fabtech Technologies Limited
• TAKE LIMITED
• Deep Health AI India Limited